Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-24 @ 4:35 PM
NCT ID:
NCT04298866
Eligibility Criteria:
Inclusion Criteria:
* Subjects or patients with MRI defined cerebral small vessel disease including different extents of white matter hyperintensities, presumably related to hypertension (30 patients), cerebral amyloid angiopathy (30 patients), CADASIL (30 patients) or any other monogenic form of cerebral small vessel disease (HTRA1 AD, COLIVA1… 10 patients)
* Age ≥ 18 years
* No dementia (MMSE \> 24 and absence of dependence in daily activities)
* No disability (modified Rankin's scale \< 2)
* No history of severe allergic reaction, in particular to gadolinium infusion
* No history of severe asthma
* No renal insufficiency (clearance \< 60 ml/mn/1.73 m2)
Exclusion Criteria:
* Contraindications to MRI
* Standard MRI of bad quality due to movement artefacts
* Dementia or disability
* Patient without affiliation to the French social security
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04298866
Study Brief:
Protocol Section:
NCT04298866